← Leaderboards
Basabi Rana
Jesse Brown Va Medical Center
$2,081,612
Attributed
$2,081,612
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $645.1K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,081,612 · 3
VA$0 · 3
By mechanism
R01$1,622,012 · 1
R21$299,700 · 1
R03$159,900 · 1
I01$0 · 3
Top collaborators
No co-investigators on record.
Most similar at Jesse Brown Va Medical Center
Same institution · by research overlap
- Ajay Nmn Rana$4,853,289
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FutureDesignMediatingSignal TransductionPharmaceutical PreparationsMolecularCause Of DeathMalignant Epithelial CellIn VivoOverexpressionEventPhosphotransferasesSignal PathwayBeta CateninMalignant Neoplasm Of Gastrointestinal TractBaseMalignant NeoplasmsPathway InteractionsBay 54-9085Primary Carcinoma Of The Liver CellsMixed Lineage Kinase 3ReportingCancer CellMediator Of Activation Protein
Grant awards (23)
Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma$0
I01 · FY2025 · VA · contact PI
Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma$0
I01 · FY2024 · VA · contact PI
Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma$0
I01 · FY2023 · VA · contact PI
Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma$0
I01 · FY2022 · VA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2022 · VA · contact PI
Mechanistic Insight on the Role of Berberine and AMPK in Hepatocellular Carcinoma$79,950
R03 · FY2020 · CA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2020 · VA · contact PI
Mechanistic Insight on the Role of Berberine and AMPK in Hepatocellular Carcinoma$79,950
R03 · FY2019 · CA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2019 · VA · contact PI
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma$331,793
R01 · FY2018 · CA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2018 · VA · contact PI
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma$331,793
R01 · FY2017 · CA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2017 · VA · contact PI
Elucidation of MLK3 Signaling in Hepatocellular Carcinoma$0
I01 · FY2016 · VA · contact PI
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma$331,776
R01 · FY2015 · CA · contact PI
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma$313,325
R01 · FY2015 · CA · contact PI
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma$313,325
R01 · FY2014 · CA · contact PI
Molecular Mechanisms of Gastrin Mediated Pathways in Gastric Cancer Cells$0
I01 · FY2014 · VA · contact PI
Molecular Mechanisms of Gastrin Mediated Pathways in Gastric Cancer Cells$0
I01 · FY2013 · VA · contact PI
Molecular Mechanisms of Gastrin Mediated Pathways in Gastric Cancer Cells$0
I01 · FY2012 · VA · contact PI
Molecular Mechanisms of Gastrin Mediated Pathways in Gastric Cancer Cells$0
I01 · FY2011 · VA · contact PI
Role of MLK3 in beta catenin signaling in prostate cancer$148,500
R21 · FY2008 · CA · contact PI
Role of MLK3 in beta catenin signaling in prostate cancer$151,200
R21 · FY2007 · CA · contact PI